Research Excellence

Awards and Honors

Abhijit Patel, MD, PhD, Assistant Professor of Therapeutic Radiology and a member of the Radiobiology and Radiotherapy Program received a $200K grant from the Brozman Foundation to study "Ultrasensitive detection of tumor DNA in blood for early diagnosis of ovarian cancer."


 Read More...

Research Excellence

Research Excellence

Evan Morris, PhD, a member of Yale Cancer Center's Radiobiology and Radiotherapy Program, has been awarded a Fulbright Scholar grant to conduct research and teach at Hadassah Hospital and Hebrew University in Jerusalem
 

Working Toward a Cure

Research Excellence
Katie Politi

Mutations in the Epidermal Growth Factor Receptor (EGFR) are found in 10-20% of lung adenocarcinomas. These mutations are most common in tumors in never-smokers and are associated with sensitivity to drugs... Read more...  

Research Excellence

Awards and Honors

Abhijit Patel, MD, PhD, Assistant Professor of Therapeutic Radiology and a member of the Radiobiology and Radiotherapy Program received a $200K grant from the Brozman Foundation to study "Ultrasensitive detection of tumor DNA in blood for early diagnosis of ovarian cancer."


 Read More...

Research Excellence

Awards and Honors

Peter Glazer, Alanna Schepartz, Craig Crews, and Vasilis Vasiliou, were recently elected into the Connecticut Academy of Science and Engineering. Election to the Academy is on the basis of scientific and engineering distinction achieved through significant contributions in scientific and engineering excellence. 

Research Excellence

Awards and Honors

Joseph Schlessinger, PhD, the William H. Prusoff Professor of Pharmacology has been awarded the 2015 Frontiers of Knowledge Award in Biomedicine from the Madrid-based BBVA Foundation in recognition of his work leading to the first personalized treatments for cancer. Read more...


 

Working Toward a Cure

Research Excellence
David Stern

The HER-2/Neu/ErbB-2 receptor tyrosine kinase is a major human oncogene and a validated therapeutic target in breast cancer. We are investigating the normal and carcinogenic functions of HER2 and other EGF receptor family kinases to understand how they cause cancers. Read More...  

Working Toward a Cure

Qin Yan, PhDhas been awarded an R21 Grant from the National Cancer Institute to study the roles of epigenetic regulators in breast cancer metastasis. The $398,352 grant will be conducted with Drs. Don Nguyen, Narendra Wajapeyee, and David Rimm.


 

Working Toward a Cure

Xiaoyong Yang, PhD, Associate Professor of Comparative Medicine and a member of the Signal Transduction Program, has received an American Cancer Society Research Scholar Grant to study the Control of Cancer Metabolism by O-Linked Glycosylation. The four-year grant totals $792,000.